XML 22 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Supplementary Information
9 Months Ended
Sep. 30, 2021
Supplementary Information [Abstract]  
Supplementary Information

4.

Supplementary Information

Cash, cash equivalents and restricted cash

The Company considers all highly liquid investments with original or remaining maturities of 90 days or less at the date of purchase to be cash equivalents. Cash and cash equivalents are recorded at cost, which approximates fair value. Restricted cash is included in other long-term assets on the consolidated balance sheets. The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets that sum to the total of the amounts reported in the consolidated statement of cash flows (in thousands):

 

 

 

September 30, 2021

 

December 31, 2020

 

Cash and cash equivalents

 

$

455,858

 

$

241,221

 

Restricted cash included in other long-term assets

 

 

156

 

 

326

 

Total cash, cash equivalents, and restricted cash

 

$

456,014

 

$

241,547

 

 

Restricted cash represents amounts required for a contractual agreement with an insurer for the payment of potential health insurance claims, and term deposits for bank guarantees.

Property and equipment, net

Property and equipment consisted of the following (in thousands):

 

 

 

September 30,

 

 

December 31,

 

 

 

2021

 

 

2020

 

Land

 

$

9,896

 

 

$

10,067

 

Building and improvements

 

 

15,722

 

 

 

15,630

 

Computer equipment and software

 

 

44,182

 

 

 

41,451

 

Furniture, equipment and other

 

 

13,463

 

 

 

10,136

 

Leasehold improvements

 

 

9,870

 

 

 

9,652

 

Right-of-use assets under finance leases

 

 

2,564

 

 

 

2,665

 

Total property and equipment

 

 

95,697

 

 

 

89,601

 

Less: accumulated depreciation and amortization

 

 

56,986

 

 

 

53,269

 

Property and equipment, net

 

$

38,711

 

 

$

36,332

 

 

Depreciation expense, including amortization of right-of-use assets under finance leases, was $1.7 million and $5.4 million, respectively, for the three and nine months ended September 30, 2021, and $1.7 million and $5.5 million, respectively, for the three and nine months ended September 30, 2020.

Other liabilities

The following table provides the details of other accrued expenses and current liabilities (in thousands):

 

 

 

September 30,

 

 

December 31,

 

 

 

2021

 

 

2020

 

Income taxes payable

 

$

4,367

 

 

$

7,250

 

Accrued VAT

 

 

3,625

 

 

 

6,604

 

Accrued professional fees

 

 

3,577

 

 

 

3,156

 

Accrued royalties

 

 

2,263

 

 

 

2,009

 

Defined contribution plan liabilities

 

 

1,565

 

 

 

1,660

 

Obligations for acquisition of businesses

 

 

1,502

 

 

 

1,957

 

Insurance reserves

 

 

1,034

 

 

 

843

 

Other current liabilities

 

 

6,788

 

 

 

7,925

 

Total

 

$

24,721

 

 

$

31,404

 

 

The following table provides details of other long-term liabilities (in thousands):

 

 

 

September 30,

 

 

December 31,

 

 

 

2021

 

 

2020

 

Pension and other post retirement liabilities

 

$

15,226

 

 

$

14,497

 

Deferred tax liabilities

 

 

8,138

 

 

 

8,028

 

Other long-term liabilities

 

 

9,277

 

 

 

5,242

 

Total

 

$

32,641

 

 

$

27,767

 

Private placement financing

In September 2021, the Company issued 2,935,564 shares of its Class A common stock in a private placement to Matrix Capital Management Company LP, for aggregate proceeds of $200.0 million. Per the terms of the agreement, the shares are subject to a one-year lockup period.

The Company expects to use the proceeds for general corporate purposes.

The securities issued in the private placement have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state or other applicable jurisdiction’s securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state or other jurisdictions’ securities laws. The Company has agreed to have a registration statement with the U.S. Securities and Exchange Commission (the “SEC”) registering the resale of the shares of common stock issued in the private placement declared or deemed effective by the SEC no later than the one-year anniversary after the closing of the private placement.

Restructuring expense

During the first quarter of 2021, the Company initiated a restructuring plan to realign resources with the Company’s current business outlook and cost structure. The restructuring plan resulted in charges for employee termination benefits of $(0.1) million and $5.0 million for the three and nine months ended September 30, 2021, respectively. The Company expects remaining costs will be immaterial, and all amounts will be paid in 2021. The restructuring costs are attributable primarily to the Software reportable segment.

Restructuring expense was recorded as follows (in thousands):

 

 

Three Months Ended

September 30, 2021

 

 

Nine Months Ended

September 30, 2021

 

Cost of revenue – maintenance and other services

 

$

36

 

 

$

866

 

Cost of revenue – software related services

 

 

(46

)

 

 

60

 

Research and development

 

 

(24

)

 

 

1,721

 

Sales and marketing

 

 

(90

)

 

 

1,836

 

General and administrative

 

 

 

 

 

471

 

Total restructuring expense

 

$

(124

)

 

$

4,954

 

 

Other expense (income), net

Other expense (income), net consists of the following (in thousands):

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Foreign exchange loss (gain)

 

$

226

 

 

$

(691

)

 

$

1,942

 

 

$

(723

)

Interest income and other

 

 

(102

)

 

 

(91

)

 

 

(275

)

 

 

(1,129

)

Other expense (income), net

 

$

124

 

 

$

(782

)

 

$

1,667

 

 

$

(1,852

)